Psychotic Disorders: all 1,655 studies
Page 15 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.
- Impact of Genetic Counseling for Individuals With Mental IllnessCompletedNCT00713804Phase 3
- Cannabinoids, Neural Synchrony, and Information ProcessingCompletedNCT00708994Early Phase 1
- Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)WithdrawnNCT00702793Phase 4
- A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like PsychosesTerminatedNCT00701753
- Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
- A German Multicenter Study on Toxoplasma Gondii in First-episode SchizophreniaStatus unknownNCT00686400
- Specialized Clozapine Clinic for Bipolar and Schizoaffective DisorderCompletedNCT00683709
- Adherence in Adolescents and Children Treated on QuetiapineCompletedNCT00680888
- Cardio Risk of Acute Schizophrenia Olanzapine DukeWithdrawnNCT00672464Phase 4
- Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative StudyCompletedNCT00670371
- Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental IllnessCompletedNCT00661869Not applicable
- Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for PsychosisCompletedNCT00655239Not applicable
- A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
- A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
- A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.CompletedNCT00645502Phase 1
- A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective DisorderTerminatedNCT00645229Phase 3
- Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable RisperidoneCompletedNCT00644852
- A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
- Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient AdmissionCompletedNCT00627510
- Evaluation of Programs of Coordinated Care and Disease ManagementStatus unknownNCT00627029Not applicable
- Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental IllnessCompletedNCT00621465Not applicable
- Schizophrenic Patients Taking Part in Integrated Care ProgramTerminatedNCT00617214
- Efficacy of Pregnenolone in Patients With SchizophreniaCompletedNCT00615511Phase 2
- Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)CompletedNCT00579267
- Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
- Study of the Effects of Glycine on Symptoms and Memory in Patients With SchizophreniaTerminatedNCT00575848Phase 1
- Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-EffectsCompletedNCT00567034Phase 1
- Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than RisperidoneStatus unknownNCT00563017Not applicable
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.CompletedNCT00558298Phase 3
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic AgentsCompletedNCT00545467Phase 4
- Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic DisorderStatus unknownNCT00541502
- Changes in Heart Rhythms Associated With Antipsychotic Drug TreatmentCompletedNCT00538122
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia PatientsWithdrawnNCT00534898Phase 3
- An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCompletedNCT00526877Phase 4
- Seroquel Long-Term NIS for Schizophrenia PatientsCompletedNCT00523783
- Recovery Group PilotCompletedNCT00522613Not applicable
- Efficacy of an Occupational Time Use Intervention for People With Serious Mental IllnessCompletedNCT00520728Phase 1
- Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4
- Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic PatientsTerminatedNCT00515489
- How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance ProgramsCompletedNCT00514423Not applicable
- Study on the Safety of Risperidone on Obese or Overweight Patients With SchizophreniaTerminatedNCT00511628
- Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot StudyCompletedNCT00511277Phase 4
- Contingency Management for Smoking Cessation Among Veterans With Psychotic DisordersTerminatedNCT00508560Not applicable
- Complex Problem Solving Training in Schizophrenic PatientsCompletedNCT00507988Not applicable
- Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective DisorderCompletedNCT00501618Phase 4
- Enhancing Motivation To Quit Smoking In Smokers With Serious Mental IllnessCompletedNCT00500695Phase 1
- A Comparison of Two Cognitive Batteries in People With SchizophreniaCompletedNCT00499044Not applicable
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.CompletedNCT00495118Phase 3
- Sarcosine or D-Serine Add-on Treatment for Chronic SchizophreniaCompletedNCT00491569Phase 2
- ACP-104 in Acutely Psychotic Subjects With SchizophreniaCompletedNCT00490516Phase 2
- FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute PsychosisTerminatedNCT00486798Phase 3
- Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and PsychosisCompletedNCT00484302Not applicable
- Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective DisorderCompletedNCT00480571Phase 2
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in SchizophreniaStatus unknownNCT00469664Phase 4
- Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisStatus unknownNCT00465920Phase 2
- Donepezil Double Blind Trial for ECT Memory DisfunctionStatus unknownNCT00465283Phase 4
- Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With SchizophreniaCompletedNCT00463372Phase 1
- The Effectiveness of Supported Employment for People With Severe Mental Illness: an RCT in Six European CountriesCompletedNCT00461318Not applicable
- RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical PracticeCompletedNCT00458367
- Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNCT00457899Phase 3
- Rapid Tranquillization Trial: TREC-India IICompletedNCT00455234Phase 3
- Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.CompletedNCT00454883
- Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)CompletedNCT00453804Phase 4
- Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)CompletedNCT00453609Phase 4
- Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCompletedNCT00449397Phase 3
- Facilitated Referral for Children Screening Positive for Mental IllnessCompletedNCT00448331
- Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use DisordersCompletedNCT00447733Not applicable
- Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary CareCompletedNCT00446407Not applicable
- Zyprexa and Task Engagement in SchizophreniaWithdrawnNCT00440843Phase 3
- Families Coping With Mental Illness ProgramStatus unknownNCT00435721Phase 1
- Family-Directed Cognitive Adaptation Program for Individuals With SchizophreniaCompletedNCT00434980Not applicable
- Work Activity Augmented by Cognitive Rehabilitation for SchizophreniaCompletedNCT00430560Phase 2/3
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Phase 3 /Seroquel SR Acute Mania Monotherapy - USCompletedNCT00422123Phase 3
- A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic TreatmentCompletedNCT00420823Phase 2/3
- Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and AntioxidantsCompletedNCT00419146Phase 2/3
- Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
- Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With SchizophreniaCompletedNCT00407277Not applicable
- Effect of High-Dose B-Complex Vitamins on the Symptoms of SchizophreniaCompletedNCT00403247Not applicable
- Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in SchizophreniaCompletedNCT00401089Phase 1/2
- Recovery Guide Intervention for Recurrent Psychiatric HospitalizationCompletedNCT00400166Not applicable
- PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersCompletedNCT00399334
- Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for PsychosisCompletedNCT00396643Phase 4
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective DisorderCompletedNCT00395031Phase 2/3
- Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.Status unknownNCT00392249Phase 1/2
- An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.CompletedNCT00391261Phase 4
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
- Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part IICompletedNCT00377117
- The Effects of Nicotine Withdrawal on Reward Responsivity in SchizophreniaCompletedNCT00373126Phase 4
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisCompletedNCT00369239Phase 4
- Cost Effective Treatment for Dually Diagnosed HomelessCompletedNCT00368524Not applicable
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181
- Tetrabenazine for Partial RespondersCompletedNCT00362804Not applicable
- Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaCompletedNCT00361543Phase 4
- Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art InterventionsCompletedNCT00358709Phase 3
- Cognitive Therapy for Negative Symptoms and FunctioningCompletedNCT00350883Phase 2
- Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic IllnessCompletedNCT00350493
- Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility StudyCompletedNCT00350311Phase 2